Ezetimibe reduces plasma cholesterol and inhibits the development of atherosclerosis in apo E knockout mice with and without LDL receptors

被引:0
|
作者
Davis, HR [1 ]
Compton, DS [1 ]
Hoos, LM [1 ]
Tetzloff, GG [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
899
引用
收藏
页码:186 / 186
页数:1
相关论文
共 50 条
  • [21] Xenogenic macrophage immunization reduces atherosclerosis in apolipoprotein E knockout mice
    Yamashita, Tomoya
    Kawashima, Seinosuke
    Hirase, Tetsuaki
    Shinohara, Masakazu
    Takaya, Tomofumi
    Sasaki, Naoto
    Takeda, Masafumi
    Tawa, Hideto
    Inoue, Nobutaka
    Hirata, Ken-ichi
    Yokoyama, Mitsuhiro
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (03): : C865 - C873
  • [22] Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice
    van der Sluis, Ronald J.
    Nahon, Joya E.
    Reuwer, Anne Q.
    Van Eck, Miranda
    Hoekstra, Menno
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (09) : 2397 - 2405
  • [23] Preventive effects of grapefruit juice on progression of atherosclerosis in APO-E knockout mice
    Ichiyama, I
    Asai, T
    Watanabe, M
    Kitahara, Y
    Sato, Y
    Kanbe, S
    Harasawa, S
    Okubo, K
    Hisalki, R
    Fujita, H
    Takahashi, A
    Abeta, H
    Saito, F
    Otsuka, Y
    Kushiro, T
    JOURNAL OF HYPERTENSION, 2005, 23 : S74 - S74
  • [24] GRAPEFRUIT PECTIN REDUCES PLASMA TOTAL CHOLESTEROL, LDL CHOLESTEROL, AND RETARDS ATHEROSCLEROSIS IN MICROSWINE WITH PROLONGED HYPERCHOLESTEROLEMIA
    SULLIVAN, M
    CERDA, J
    BURGIN, C
    ROBBINS, F
    NORMANN, S
    CLINICAL RESEARCH, 1991, 39 (02): : A656 - A656
  • [25] Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice
    Thacker, Seth G.
    Rousset, Xavier
    Esmail, Safiya
    Zarzour, Abdalrahman
    Jin, Xueting
    Collins, Heidi L.
    Sampson, Maureen
    Stonik, John
    Demosky, Stephen
    Malide, Daniela A.
    Freeman, Lita
    Vaisman, Boris L.
    Kruth, Howard S.
    Adelman, Steven J.
    Remaley, Alan T.
    JOURNAL OF LIPID RESEARCH, 2015, 56 (07) : 1282 - 1295
  • [26] BM-573, a thromboxane receptor antagonist, reduces development of atherosclerosis in apo E-deficient mice
    Cherdon, C.
    Rolin, S.
    Hanson, J.
    Drion, P. V.
    De Leval, L.
    Defraigne, J. O.
    Dogne, J. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S33 - S34
  • [27] Xenogenic macrophage immunization as a vaccine reduces atherosclerosis in apolipoprotein E knockout mice
    Yamashita, T
    Kawashima, S
    Ozaki, M
    Shinohara, M
    Inoue, N
    Hirata, K
    Yokoyama, M
    CIRCULATION, 2002, 106 (19) : 182 - 182
  • [28] Toll-like receptor 4 deficiency reduces atherosclerosis and alters plaque phenotype in Apo E-null mice without changing circulating cholesterol levels
    Michelsen, KS
    Wong, MH
    Zhang, WX
    Yano, J
    Rajavashisth, TB
    Doherty, TM
    Shah, PK
    Arditi, M
    CIRCULATION, 2004, 110 (17) : 177 - 177
  • [29] Marked suppression of plasma LDL cholesterol levels in the LDLR knockout mice overexpressing ApoE
    Osuga, J
    Ishibashi, S
    Yonemoto, M
    Shimano, H
    Yagyu, H
    Harada, K
    Ohashi, K
    Kamei, T
    Yamada, N
    CIRCULATION, 1997, 96 (08) : 589 - 589
  • [30] 3-Deazaadenosin (c3Ado) lowers plasma homocysteine level and inhibits the development of atherosclerotic lesions in Apo E knockout mice
    Langheinrich, AC
    Walker, G
    Jeide, I
    Braun-Dullaeus, RC
    Bohle, RM
    Waas, W
    Haberbosch, W
    EUROPEAN HEART JOURNAL, 2000, 21 : 128 - 128